Skip to main content
Clinical Trials/ACTRN12617000906358
ACTRN12617000906358
Completed
未知

A prospective study to evaluate the safety and performance of a shape memory polymer foam embolization device for arterial or venous embolization of the peripheral vasculature system by assessing rates of serious adverse events and unanticipated serious adverse device effects from the day of procedure through 30 days post-procedure.

Shape Memory Medical Inc0 sites11 target enrollmentJune 20, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
arterial or venous condition requiring embolization
Sponsor
Shape Memory Medical Inc
Enrollment
11
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 20, 2017
End Date
June 19, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Study Participant is greater than or equal to 18 years of age and less than or equal to 75 years of age;
  • Study Participant is considered a candidate for arterial or venous embolization of the peripheral vasculature;
  • Study Participant has a target vessel \>2 mm and \<9 mm in diameter, measured during angiographic imaging.

Exclusion Criteria

  • Study Participant has an inability to provide written informed consent;
  • Study Participant has inappropriate anatomy of the vasculature for the safe access and/or the deployment of the study device,
  • Study Participant has known hypersensitivity or contraindication to nickel or nitinol;
  • Study Participant has a condition that inhibits radiographic visualization during the implantation procedure;
  • Study Participant has a history of allergy to contrast medium that cannot be managed medically;
  • Study Participant has an uncontrolled co\-morbid medical condition that would adversely affect participation in the Study;
  • Study Participant is pregnant or a lactating female.

Outcomes

Primary Outcomes

Not specified

Similar Trials